Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06166017Not Yet Recruiting

Lingual Keratinized Tissue in Fully Edentulous Patients and Its Impact on Implant Health

Role: lead

NCT06234800Completed

Observational Study on Implant Removal

Role: lead

NCT04337645Not ApplicableUnknown

Resective Surgical Treatment of Peri-implantitis.

Role: collaborator

NCT04323540Not ApplicableUnknown

Treatment of Peri-implantitis With or Without Simultaneous Soft Tissue Augmentation

Role: lead

All 4 trials loaded